logo
Beyond HumanBig PictureCatalystsConnected WorldExchangeMarketing MixNew MoneyNew SchoolPeople SciencePulse

An inefficient clinical trials system is hindering therapeutics discovery. What’s the solution?

Roy Smythe

Better understanding of human biology has lead to a growing number of potential therapeutics. But what benefit is this if they are not being validated and distributed?

Roy Smythe, Chief Medical Officer, Strategy and Partnerships for Philips, at the time of filming, believes that our healthcare system is failing. Vital treatments aren’t being investigated, validated and distributed due to an inefficient clinical trials process, and despite overspending on healthcare in the developed world, elsewhere, access to effective healthcare is patchy.

Could changing the way we trial potential treatments in the medically developed world be the first step in evolving the global healthcare system?

This interview is part of ‘The Age of Transformation: How Pharma can Harness the Power of Data’, a series powered by Medidata.

CHANNELS